Company intelligence / Profile preview

Bayer HealthCare

Leverkusen, North Rhine-Westphalia, Germany

Ownership: Private
Employees: ~99000
Development stage: Commercial

Overview

Bayer’s pharmaceutical division, Bayer HealthCare Pharmaceuticals, commercializes multiple globally approved drugs such as rivaroxaban (an anticoagulant), ethinyl estradiol/drospirenone (contraceptive), and others across diverse therapeutic categories, with several late-stage and marketed therapies[1][3].

Therapeutic areas: NephrologyOphthalmologyInfectious DiseasesHematologyPulmonologyCardiovascularOncologyWomen's Health
Modalities: Small moleculeBiologicMonoclonal antibodyProteinPeptidesHormoneVaccine
Industry: Pharma

Drug pipeline

60 assets

prednicarbate

Approved

59 more assets in the full pipeline.

Request access →

Partnerships

Regeneron (aflibercept)Merck & Co. (previous collaborations)Boehringer Ingelheim (diabetes drugs)Evotec (drug discovery collaborations)

Beyond the preview

Go deeper on Bayer HealthCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bayer HealthCare.

Explore the full profile